In case you missed it: Jan. 3 to Jan. 7
What you missed this week in women's health
This week's must-read stories included:
Using certain hair products during pregnancy may negatively impact maternal hormone levels
The use of hair dyes, bleach, relaxers, and mousse was associated with lower levels of sex steroid hormones in pregnant women, according to a new Rutgers study.
Detecting Candida albicans via feminine hygiene products
A home kit to detect urinary tract infections (UTIs) like Candida albicans from vaginal fluids on sanitary napkins and tampons could soon enter the clinical phase.
SMFM opts for virtual format ahead of 2022 annual meeting
The Society for Maternal-Fetal Medicine has announced its upcoming 2022 annual meeting will now be virtual.
Poll: Will new technology bring a resurgence in enthusiasm for single port surgery?
Do you expect new technology, like vNOTES, to revive the industry's enthusiasm for single-port surgery?
Expanding treatment horizons for vaginal stenosis
While it has been nearly 50 years since vaginal dilators were introduced as a therapy to decrease VS, the medical community still knows very little about the potential impact on long-term outcomes.
New blood test could predict women at risk for preeclampsia
An experimental blood test uses plasma cell-free RNA (cfRNA) to accurately predict preeclampsia as early as 16 weeks.
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
IUD placement within 48 hours nonsuperior vs 2 to 4 weeks after abortion
November 19th 2024A study reveals no significant difference in 6-month intrauterine device use between placements within 48 hours or 2 to 4 weeks after a second-trimester abortion, though earlier placement carries a higher expulsion risk.
Read More
